CCN2 and systemic sclerosis: The fibroblasts in SSc exhibit constitutive activation driven by molecular mediators such as transforming growth factor-beta (TGF-β), connective tissue growth factor (CTGF), and other cytokines, resulting in unchecked collagen production and reduced degradation.